{"generic":"Magnesium Hydroxide","drugs":["Dulcolax Milk of Magnesia","Magnesium Hydroxide","Phillips Milk of Magnesia","QC Milk of Magnesia"],"mono":{"0":{"id":"7lpcs0","title":"Generic Names","mono":"Magnesium Hydroxide"},"1":{"id":"7lpcs1","title":"Dosing and Indications","sub":{"0":{"id":"7lpcs1b4","title":"Adult Dosing","mono":"<ul><li>Each mg of magnesium hydroxide contains 0.42 mg elemental magnesium<\/li><li><b>Constipation:<\/b> Chewable tablet, 8 tablets (2488 mg magnesium hydroxide; 1040 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 8 tablets in 24 hours<\/li><li><b>Constipation:<\/b> Concentrated liquid, 15 to 30 mL (2400 to 4800 mg magnesium hydroxide; 1000 to 2000 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 30 mL in 24 hours<\/li><li><b>Constipation:<\/b> Liquid, 30 to 60 mL (2400 to 4800 mg magnesium hydroxide; 1000 to 2000 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 60 mL in 24 hours<\/li><li><b>Indigestion:<\/b> 2 to 4 chewable tablets (622 to 1244 mg magnesium hydroxide; 260 to 520 mg elemental magnesium) ORALLY every 4 hours up to 4 times within a 24-hour period; MAX in 24 hours: 16 tablets (4976 mg magnesium hydroxide; 2080 mg elemental magnesium)<\/li><\/ul>"},"1":{"id":"7lpcs1b5","title":"Pediatric Dosing","mono":"<ul><li>Each mg of magnesium hydroxide contains 0.42 mg elemental magnesium<\/li><li><b>Constipation:<\/b> Chewable tablet (Pedia-Lax(R), 2 to 5 years): 1 to 3 tablets (400 to 1200 mg magnesium hydroxide; 170 to 510 mg elemental magnesium) ORALLY as single daily dose OR in divided doses; take with 8 ounces liquid; MAX: 3 tablets\/day<\/li><li><b>Constipation:<\/b> Chewable tablet (Pedia-Lax(R), 6 to 11 years): 3 to 6 tablets (1200 to 2400 mg magnesium hydroxide; 510 to 1020 mg elemental magnesium) ORALLY as single daily dose OR in divided doses; take with 8 ounces liquid; MAX: 6 tablets\/day<\/li><li><b>Constipation:<\/b> Chewable tablet (Phillips'(R), 3 to 5 years): 2 tablets (622 mg magnesium hydroxide; 260 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 2 tablets in 24 hours<\/li><li><b>Constipation:<\/b> Chewable tablet (Phillips'(R), 6 to 11 years): 4 tablets (1244 mg magnesium hydroxide; 520 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 4 tablets in 24 hours<\/li><li><b>Constipation:<\/b> Chewable tablet (Phillips'(R), 12 years or older): 8 tablets (2488 mg magnesium hydroxide; 1040 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 8 tablets in 24 hours<\/li><li><b>Constipation:<\/b> Concentrated liquid (12 years or older): 15 to 30 mL (2400 to 4800 mg magnesium hydroxide; 1000 to 2000 mg elemental magnesium) ORALLY once, daily preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 30 mL in 24 hours<\/li><li><b>Constipation:<\/b> Liquid (12 years or older): 30 to 60 mL (2400 to 4800 mg magnesium hydroxide; 1000 to 2000 mg elemental magnesium)  ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 60 mL in 24 hours<\/li><li><b>Constipation:<\/b> Liquid (6 through 11 years): 15 to 30 mL (1200 to 2400 mg magnesium hydroxide; 500 to 1000 mg elemental magnesium) ORALLY once daily, preferably at bedtime, OR in divided doses; take with 8 ounces liquid; MAX: 30 mL in 24 hours<\/li><li><b>Indigestion:<\/b> Phillips'(R), 12 years or older: 2 to 4 chewable tablets (622 to 1244 mg magnesium hydroxide; 260 to 520 mg elemental magnesium) ORALLY every 4 hours up to 4 times within a 24-hour period; MAX in 24 hours: 16 tablets (4976 mg magnesium hydroxide; 2080 mg elemental magnesium)<\/li><\/ul>"},"3":{"id":"7lpcs1b7","title":"Indications","mono":"<b>Non-FDA Labeled Indications<\/b><ul><li>Calcium renal calculus; Prophylaxis<\/li><li>Constipation<\/li><li>Indigestion<\/li><\/ul>"}}},"3":{"id":"7lpcs3","title":"Contraindications\/Warnings","sub":[{"id":"7lpcs3b9","title":"Contraindications","mono":"Specific contraindications have not been determined <br\/>"},{"id":"7lpcs3b10","title":"Precautions","mono":"<ul><li>Endocrine Metabolic:<\/li><li>-- Use caution in patients with a magnesium-restricted diet<\/li><li>Gastrointestinal:<\/li><li>-- Laxative effect may occur if chewable tablets are used as an antacid<\/li><li>-- Use caution in patients with nausea, abdominal pain, or vomiting<\/li><li>-- Use caution in patients with a sudden change in bowel habits that persists for more than 14 days<\/li><li>Renal:<\/li><li>-- Use caution in patients with renal disease<\/li><\/ul>"},{"id":"7lpcs3b11","title":"Pregnancy Category","mono":"Magnesium: D (FDA)<br\/>"},{"id":"7lpcs3b12","title":"Breast Feeding","mono":"<ul><li>Magnesium: AAP: Maternal medication usually compatible with breastfeeding.<\/li><li>Magnesium: WHO: Compatible with breastfeeding.<\/li><li>Magnesium: Micromedex: Infant risk is minimal.<\/li><\/ul>"}]},"4":{"id":"7lpcs4","title":"Drug Interactions","sub":{"1":{"id":"7lpcs4b14","title":"Major","mono":"<ul><li>Dabrafenib (theoretical)<\/li><li>Eltrombopag (established)<\/li><li>Elvitegravir (established)<\/li><li>Ketoconazole (probable)<\/li><li>Ledipasvir (theoretical)<\/li><li>Levomethadyl (theoretical)<\/li><li>Licorice (theoretical)<\/li><li>Mycophenolate Mofetil (probable)<\/li><li>Mycophenolic Acid (established)<\/li><li>Pazopanib (theoretical)<\/li><li>Phenytoin (theoretical)<\/li><li>Quinine (theoretical)<\/li><li>Raltegravir (established)<\/li><li>Rilpivirine (theoretical)<\/li><li>Vismodegib (theoretical)<\/li><\/ul>"},"2":{"id":"7lpcs4b15","title":"Moderate","mono":"<ul><li>Amprenavir (probable)<\/li><li>Atevirdine (probable)<\/li><li>Cefditoren Pivoxil (probable)<\/li><li>Chloroquine (probable)<\/li><li>Chlortetracycline (probable)<\/li><li>Ciprofloxacin (probable)<\/li><li>Clofazimine (established)<\/li><li>Dasatinib (established)<\/li><li>Delavirdine (probable)<\/li><li>Demeclocycline (probable)<\/li><li>Dicumarol (probable)<\/li><li>Digoxin (probable)<\/li><li>Dolutegravir (established)<\/li><li>Doxycycline (probable)<\/li><li>Enoxacin (probable)<\/li><li>Erlotinib (probable)<\/li><li>Felodipine (probable)<\/li><li>Fexofenadine (probable)<\/li><li>Gabapentin (probable)<\/li><li>Gemifloxacin (probable)<\/li><li>Grepafloxacin (probable)<\/li><li>Isradipine (probable)<\/li><li>Levofloxacin (probable)<\/li><li>Levothyroxine (probable)<\/li><li>Lomefloxacin (probable)<\/li><li>Methacycline (probable)<\/li><li>Minocycline (probable)<\/li><li>Moxifloxacin (probable)<\/li><li>Nicardipine (probable)<\/li><li>Nifedipine (probable)<\/li><li>Norfloxacin (probable)<\/li><li>Oxytetracycline (probable)<\/li><li>Pefloxacin (probable)<\/li><li>Potassium Phosphate (probable)<\/li><li>Potassium Phosphate, Dibasic (probable)<\/li><li>Potassium Phosphate, Monobasic (probable)<\/li><li>Quinidine (probable)<\/li><li>Rocuronium (probable)<\/li><li>Rolitetracycline (probable)<\/li><li>Sodium Phosphate (probable)<\/li><li>Sodium Phosphate, Dibasic (probable)<\/li><li>Sodium Phosphate, Monobasic (probable)<\/li><li>Sodium Polystyrene Sulfonate (probable)<\/li><li>Sparfloxacin (probable)<\/li><li>Succinylcholine (probable)<\/li><li>Tacrolimus (probable)<\/li><li>Tetracycline (probable)<\/li><li>Ticlopidine (probable)<\/li><li>Tipranavir (probable)<\/li><li>Vecuronium (probable)<\/li><li>Zalcitabine (probable)<\/li><\/ul>"}}},"5":{"id":"7lpcs5","title":"Adverse Effects","mono":"<b>Serious<\/b><br\/><b>Endocrine metabolic:<\/b>Hypermagnesemia<br\/>"},"6":{"id":"7lpcs6","title":"Drug Name Info","sub":{"0":{"id":"7lpcs6b17","title":"US Trade Names","mono":"<ul><li>Phillips Milk of Magnesia<\/li><li>Dulcolax Milk of Magnesia<\/li><li>QC Milk of Magnesia<\/li><\/ul>"},"2":{"id":"7lpcs6b19","title":"Class","mono":"<ul><li>Antacid, Magnesium Containing<\/li><li>Laxative<\/li><\/ul>"},"3":{"id":"7lpcs6b20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"7lpcs6b21","title":"Generic Availability","mono":"Yes<br\/>"}}},"9":{"id":"7lpcs9","title":"Administration","mono":"<b>Oral<\/b><br\/>Shake liquid formulations well before use.<br\/>"},"11":{"id":"7lpcs11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Oral Solution: 400 MG\/5 ML<\/li><li>Oral Suspension: 1200 MG\/5 ML<\/li><\/ul><\/li><li><b>Dulcolax Milk of Magnesia<\/b><br\/>Oral Suspension: 400 MG\/5 ML<br\/><\/li><li><b>Good Neighbor Pharmacy Milk of Magnesia<\/b><br\/>Oral Suspension: 1200 MG\/15 ML<br\/><\/li><li><b>Good Sense Milk of Magnesia<\/b><br\/>Oral Suspension: 400 MG\/5 ML<br\/><\/li><li><b>Milk Of Magnesia<\/b><br\/><ul><li>Oral Solution: 400 MG\/5 ML<\/li><li>Oral Suspension: 400 MG\/5 ML, 1200 MG\/15 ML, 1200 MG\/5 ML<\/li><\/ul><\/li><li><b>Pedia-Lax<\/b><br\/>Oral Tablet, Chewable: 400 MG<br\/><\/li><li><b>Phillips Milk Of Magnesia<\/b><br\/>Oral Suspension: 400 MG\/5 ML<br\/><\/li><li><b>Quality Choice Milk of Magnesia<\/b><br\/>Oral Suspension: 400 MG\/5 ML<br\/><\/li><li><b>Rite Aid Milk of Magnesia<\/b><br\/>Oral Suspension: 400 MG\/5 ML<br\/><\/li><li><b>The Medicine Shoppe Milk of Magnesia<\/b><br\/>Oral Suspension: 400 MG\/5 ML<br\/><\/li><li><b>TopCare Milk of Magnesia<\/b><br\/>Oral Suspension: 1200 MG\/15 ML<br\/><\/li><\/ul>"},"12":{"id":"7lpcs12","title":"Toxicology","sub":[{"id":"7lpcs12b31","title":"Clinical Effects","mono":"<b>ANTACIDS <\/b><br\/>USES: Antacids are used for the treatment of heartburn, dyspepsia, gastritis, and gastroesophageal reflux. PHARMACOLOGY: These agents work by buffering hydrochloric acid in the stomach and increasing gastric pH. TOXICOLOGY: Toxicity can result from excessive bicarbonate absorption causing systemic alkalosis, or from excessive absorption of the cations in the alkaline salts (eg, calcium, magnesium, aluminum, sodium). EPIDEMIOLOGY: Exposure is common; significant toxicity is rare and generally develops from chronic excessive use rather than acute overdose. MILD TO MODERATE TOXICITY: Diarrhea or constipation can develop. Asymptomatic hypermagnesemia, hypernatremia, hypercalcemia, elevations in serum aluminum concentrations or mild volume overload may also develop after chronic excessive use. SEVERE TOXICITY: With prolonged administration and\/or excessively large doses, dysrhythmias, hypo- and hypertension, encephalopathy, acute renal failure, gastrointestinal obstruction and\/or perforation, metabolic alkalosis, fluid, electrolyte, and mineral derangements, and myopathies and osteodystrophies have been reported. Distention and\/or obstruction with perforation and hypergastrinemia have been observed with prolonged or excessive antacid administration. ADVERSE EFFECTS: Constipation or diarrhea are the most common adverse effects. <br\/>"},{"id":"7lpcs12b32","title":"Treatment","mono":"<b>ANTACIDS<\/b><br\/><ul><li>Support: MANAGEMENT OF MILD TOXICITY: No treatment is generally necessary beyond supportive care and cessation of antacid use. MANAGEMENT OF SEVERE TOXICITY: Evaluate for electrolyte abnormalities (hypernatremia, hypermagnesemia, hypercalcemia, hypophosphatemia) and volume overload and treat as necessary. Monitor ECG.<\/li><li>Decontamination: GI decontamination is not necessary because of the poor absorption from the gastrointestinal tract and lack of systemic toxicity after acute overdose.<\/li><li>Hypercalcemia: Treat with intravenous hydration; add diuretics if hypercalcemia persists.<\/li><li>Hypermagnesemia: Treat with intravenous fluids. Monitor ECG and neurologic exam (particularly deep tendon reflexes). Hemodialysis can be used to treat severe hypermagnesemia.<\/li><li>Aluminum intoxication: Generally no treatment is required beyond cessation of exposure. Deferoxamine can be used for severe aluminum intoxication, primarily in patients with renal failure.<\/li><li>Hypernatremia: Treat with intravenous hydration.<\/li><li>Congestive heart failure: Treat with nitrates and diuretics.<\/li><li>Enhanced elimination procedure: Hemodialysis can be used to correct severe hypermagnesemia or hypercalcemia but is rarely necessary.<\/li><li>Monitoring of patient: No routine laboratory studies are needed in patients with acute exposure. In patients with chronic excessive use, monitor vital signs and evaluate for clinical evidence of volume overload. Monitor fluids, serum electrolytes (including calcium, magnesium, and phosphorus), ECG, and renal function tests in symptomatic patients and those with chronic excessive use. Monitor serum aluminum concentrations in patients with encephalopathy after chronic use of aluminum containing antacids, particularly patients with renal failure.<\/li><li>Patient disposition: HOME CRITERIA: Patients with minimal GI symptoms after inadvertent exposure can be managed at home. OBSERVATION CRITERIA: Patients with deliberate self-harm exposures, persistent symptoms or long-term excessive ingestion should be sent to a healthcare facility for evaluation. ADMISSION CRITERIA: Patients with persistent electrolyte abnormalities or volume overload should be admitted.<\/li><\/ul>"},{"id":"7lpcs12b33","title":"Range of Toxicity","mono":"<b>ANTACIDS<\/b><br\/>Toxicity is very unlikely following a single acute overdose. <br\/>"}]}}}